Tesla Recalls Model...
Services: Diversified Services
Myriad Genetics Inc. (MYGN: NASDAQ)
$25.94 -0.50 | -1.89%
06/19/13 - 03:21 PM ET
Portfolios with MYGN
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProJoel Greenblatt - Gotham Ca...
- ContributorStocks Rising On Unusual Vo...
- UserDesNews
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor4 Upgraded, Undervalued Stocks
- Contributor8 Health Care Buys Ahead of...
- ProClovis Capital Management
- ProRS Investment Management
Latest MYGN Headlines from TheStreet
- Myriad Genetics To Announce Third Fiscal Quarter 2013 Results On Tuesday, May 7, 2013 04.18.13 | 04:04 pm
- Myriad Adopts RainDance's Thunderstorm Platform For Next-Generation Sequencing Based Hereditary Cancer Panel 04.17.13 | 04:04 pm
- Myriad Genetics (MYGN) Shares Cross Above 200 DMA 04.15.13 | 05:04 pm
- 3 Stocks Spiking on Big Volume 04.15.13 | 02:04 pm
- Myriad And PharmaMar Announce First Commercial Partnership With Myriad's New HRD Test 03.26.13 | 04:03 pm
- BRCA Testing Granted Preventive Care Designation Under The Affordable Care Act 03.06.13 | 07:03 am
- Myriad's Prolaris(R) Test Predicts Risk Of Prostate Cancer Recurrence In Fourth Peer Reviewed Study 03.05.13 | 07:03 am
- 5 Stocks Pushing The Diversified Services Industry Lower 03.04.13 | 12:03 pm
- Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance For Fiscal 2013 03.01.13 | 08:03 pm
- 5 Stocks Pushing The Diversified Services Industry Lower 02.12.13 | 12:02 pm
Press Releases for MYGN
- Myriad Genetics Receives The "Corporate Spirit Of Giving Award" From The Utah Philanthropy Day Committee - PR Newswire 11.02.11 | 07:11 am
- Rules-Based Medicine Reaches A Significant Milestone In Companion Diagnostic Program With Roche - PR Newswire 05.25.11 | 04:05 pm
- Rules-Based Medicine, Inc. (RBM) Partners With Institut Pasteur To Boost Innovation In Translational Research - PR Newswire 05.12.11 | 08:05 am
Partner Headlines for MYGN
- US judges cast doubts on DNA patents - Financial Times 04.15.13 | 06:04 pm
- Myriad Says US Supreme Court to Hear Isolated DNA Patent Case - Benzinga 11.30.12 | 04:11 pm
- Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics - Seeking Alpha 11.30.12 | 09:11 am
- Myriad Genetics - Momentum - Zacks 11.20.12 | 01:11 am
- Stocks Tack On More Gains; Cirrus Logic Retakes 200-Day Line - Investor's Business Daily 11.19.12 | 01:11 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- Leggett, Sherwin-Williams, DaVita Buck Weak Market - Investor's Business Daily 11.15.12 | 06:11 pm
- Strong 1Q from Myriad, Guidance Up - Analyst Blog - Zacks 11.06.12 | 09:11 am
- Stocks Improve In Late Trade; Nationstar Pares Losses - Investor's Business Daily 11.05.12 | 03:11 pm
- Myriad Remains Neutral - Analyst Blog - NASDAQ 09.21.12 | 07:09 pm
